首页> 外文期刊>Scientific reports. >Touchscreen testing reveals clinically relevant cognitive abnormalities in a mouse model of schizophrenia lacking metabotropic glutamate receptor 5
【24h】

Touchscreen testing reveals clinically relevant cognitive abnormalities in a mouse model of schizophrenia lacking metabotropic glutamate receptor 5

机译:触摸屏测试揭示了缺乏代谢型谷氨酸受体5的精神分裂症小鼠模型的临床相关认知异常

获取原文
           

摘要

Metabotropic glutamate receptor 5 (mGlu5) has been implicated in certain forms of synaptic plasticity and cognitive function. mGlu5 knockout (KO) mice and mGlu5 antagonists have been previously used to study the pathophysiology of schizophrenia as they have been shown respectively to display or induce endophenotypes relevant to schizophrenia. While schizophrenia presents with generalized cognitive impairments, the cognitive phenotype of mice lacking mGlu5 has so far only been explored using largely hippocampal-dependent spatial and contextual memory tasks. To address this, we used a touchscreen system to assess mGlu5 KO mice for pairwise visual discrimination, reversal learning, and extinction of an instrumental response requiring no discrimination. Furthermore, we tested the role of mGlu5 in working memory using the Trial-Unique Non-Matching to Location (TUNL) task utilizing pharmacological ablation. mGlu5 KO mice were impaired on discrimination learning, taking longer to reach criterion and requiring more correction learning trials. Performance on reversal learning was also impaired, with mGlu5 KO mice demonstrating a perseverative phenotype. The mGlu5 KO mice responded at a higher rate during extinction, consistent with this perseverative profile. In contrast, wildtype mice treated acutely with an mGlu5 antagonist (MTEP) showed no deficits in a touchscreen task assessing working memory. The present study demonstrates learning and memory deficits as well as an increased perseverative phenotype following constitutive loss of mGlu5 in this mouse model of schizophrenia. These findings will inform translational approaches using this preclinical model and the pursuit of mGlu5 as therapeutic target for schizophrenia and other brain disorders.
机译:代谢型谷氨酸受体5(mGlu5)与某些形式的突触可塑性和认知功能有关。 mGlu5基因敲除(KO)小鼠和mGlu5拮抗剂先前已用于研究精神分裂症的病理生理,因为它们已分别显示出显示或诱导与精神分裂症有关的内表型。尽管精神分裂症表现出普遍的认知障碍,但到目前为止,仅使用很大程度上依赖于海马依赖性的空间和背景记忆任务来探索缺乏mGlu5的小鼠的认知表型。为了解决这个问题,我们使用触摸屏系统评估mGlu5 KO小鼠的成对视觉辨别力,反向学习和不需要辨别力的仪器反应的消失。此外,我们使用药理学消融法,通过尝试独特的非匹配定位(TUNL)任务测试了mGlu5在工作记忆中的作用。 mGlu5 KO小鼠的歧视性学习受损,需要更长的时间才能达到标准,并且需要更多的纠正性学习试验。逆向学习的表现也受到损害,mGlu5 KO小鼠表现出持久的表型。在灭绝过程中,mGlu5 KO小鼠的反应速度更高,与这种持久性特征一致。相反,用mGlu5拮抗剂(MTEP)急性治疗的野生型小鼠在评估工作记忆的触摸屏任务中未显示缺陷。本研究表明在这种精神分裂症小鼠模型中,mGlu5组成性丧失后,学习和记忆障碍以及持久性表型增加。这些发现将为使用该临床前模型的转化方法和追求mGlu5作为精神分裂症和其他脑部疾病的治疗靶标提供信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号